Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function

British Journal of Pharmacology

Volumn 121, Issue 2, 1997, Pages 287-295

  Weston, Marie C ^a   Anderson, Nicola ^a   Peachell, Peter T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Basophils; Cyclic AMP; Mast cells; Mediator release; Phosphodiesterases; Rolipram

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 5 (4 ACETAMIDOPHENYL) 2(1H) PYRAZINONE; 6 [4 (1,4 DIHYDRO 4 OXO 1 PYRIDYL)PHENYL] 4,5 DIHYDRO 5 METHYL 3(2H) PYRIDAZINONE; BUCLADESINE; CYCLIC AMP; DENBUFYLLINE; DIBUTYRYL CYCLIC GMP; FORSKOLIN; HISTAMINE; IMMUNOGLOBULIN E; ISOBUTYLMETHYLXANTHINE; N HYDROXY 5,6 DIMETHOXY 2 BENZO[B]THIOPHENECARBOXIMIDAMIDE; NITRAQUAZONE; PHOSPHODIESTERASE INHIBITOR; PICLAMILAST; PROSTAGLANDIN D2; ROLIPRAM; SIGUAZODAN; THEOPHYLLINE; ZAPRINAST;

ARTICLE; BASOPHIL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HYDROLYSIS; MAST CELL; PRIORITY JOURNAL;

EID: 0030946351     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701115     Document Type: Article

References (32)

1. ALI, H. & PEARCE, F.L. (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions, 16, 138-140.
2. BANNER, K.H., ROBERTS, N.M. & PAGE, C.P. (1995). Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis. Br. J. Pharmacol., 116, 3169-3174.
3. BARNES, P.J. (1995). Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J., 8, 457-462.
4. BARNETTE, M.S., MANNING, C.D., CIESLINSKI, L.B., BURMAN, M., CHRISTENSEN, S.B. & TORPHY, T.J. (1995). The ability of phosphodiesterase IV inhibitors to suppress Superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activity. J. Pharmacol. Exp. Ther., 213, 674-679.
5. BEAVO, J.A., CONTI, M. & HEASLIP, R.J. (1994). Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol., 46, 399-405.
6. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide PDE isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 151-155.
7. CHAN, S.C. & HANIFIN, J.M. (1993). Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes. J. Lab. Clin. Med., 121, 44-51.
8. DENT, G., GIEMBYCZ, M.A., RABE, K.F. & BARNES, P.J. (1991). Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br. J. Pharmacol., 103, 1339-1346.
9. ENNIS, M. (1991). Current techniques of histamine determination: automated fluorometric assays. Handbook Exp. Pharmacol., 97, 31-38.
10. ESSAYAN, D.M., HUANG S-K., UNDEM, B.J., KAGEY-SOBOTKA, A. & LICHTENSTEIN, L.M. (1994). Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J. Immunol., 153, 3408-3416.
11. FROSSARD, N., LANDRY, Y., PAULI, G. & RUCKSTUHL, M. (1981). Effects of cyclic AMP- and cyclic GMP-phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br. J. Pharmacol., 73, 933-938.
12. FRUMAN, D.A., KLEE, C.B., BIERER, B.E. & BURAKOFF, S.J. (1992). Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc. Natl. Acad. Sci. U.S.A., 89, 3686-3690.
13. GILBERT, H.S. & ORNSTEIN, L. (1975). Basophil counting with a new staining method using alcian blue. Blood, 46, 279-282.
14. HATZELMAN, A., TENOR, H. & SCHUDT, C. (1995). Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br. J. Pharmacol., 114, 821-831.
15. HICHAMI, A., BOICHOT, E., GERMAIN, N., LEGRAND, A., MOODLEY, I. & LAGENTE, V. (1995). Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells. Eur. J. Pharmacol., 291, 91-97.
16. LICHTENSTEIN, L.M. & MARGOLIS, S. (1968). Histamine release in vitro: inhibition by catecholamines and methylxanthines. Science, 161, 902-903.
17. NICHOLSON, C.D., CHALLISS, R.A.J. & SHAHID, M. (1991). Differential modulation of tissue and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Phamacol. Sci., 12, 19-27.
18. NICHOLSON, C.D. & SHAHID, M. (1994). Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes their potential utility in the therapy of asthma. Pulmon. Pharmacol., 7, 1-18.
19. NIELSON, C.P., VESTAL, R.E., STURM, R.J. & HEASLIP, R. (1990). Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol., 86, 801-808.
20. PEACHELL, P.T., MACGLASHAN, D.W., LICHTENSTEIN, L.M. & SCHLEIMER, R.P. (1988). Regulation of human basophil and lung mast cell function by cAMP. J. Immunol., 140, 571-579.
21. PEACHELL, P.T., UNDEM, B.J., SCHLEIMER, R.P. MACGLASHAN, D.W., LICHTENSTEIN, L.M., CIESLINSKI, L.B. & TORPHY, T.J. (1992). Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immunol., 148, 2503-2510.
22. PEARCE, F.L. (1983). Mast cell heterogeneity. Trends Pharmacol. Sci., 4, 165-167.
23. REEVES, M.L., LEIGH, B.K. & ENGLAND, P.J. (1987). The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors. Biochem. J., 241, 535-541.
24. SIRAGANIAN, R.P. (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem., 57, 383-394.
25. SOUNESS J.E., CARTER, C.M., DIOCEE, B.K., HASSALL, G.A., WOOD, L.J. & TURNER, N.C. (1991). Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem. Pharmacol., 42, 937-945.
26. SOUNESS, J.E., GRIFFIN, M., MASLEN, C., EBSWORTH, K., SCOTT, L.C., POLLOCK, K., PALFREYMAN, M.N. & KARLSSON, J-A. (1996). Evidence that cAMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase conformer. Br. J. Pharmacol., 118, 649-658.
27. SOUNESS, J.E., MASLEN, C., WEBBER, S., FOSTER, M., RAEBURN, D., PALFREYMAN, M.N., ASHTON, M.J. & KARLSSON, J-A. (1995). Suppresion of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Br. J. Pharmacol., 115, 39-46.
28. TORPHY, T.J. & UNDEM, B.J. (1991). Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax, 46, 512-523.
29. TORPHY, T.J., ZHOU, H-L. & CIESLINSKI, L.B. (1992). Stimulation of beta adrenoceptors in a human monocyte cell line (U937) upregulated cyclic AMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther., 263, 1195-1205.
30. TURNER, N.C., WOOD, L.J., BURNS, F.M., GUEREMY, T. & SOUNESS, J.E. (1993). The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea pig peritoneal macrophages. Br. J. Pharmacol., 108, 876-883.
31. UNDEM, B.J., PEACHELL, P.T. & LICHTENSTEIN, L.M. (1988). Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J. Pharmacol. Exp. Ther., 247, 209-217.
32. UNDERWOOD, D.C. OSBORN, R.R., NOVAK, L.B., MATTHEWS, J.K., NEWSHOLME, S.J., UNDEM B.J., HAND, J.M. & TORPHY, T.J. (1993). Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cAMP-specific phosphodiesterae inhibitor, rolipram. J. Pharmacol. Exp. Ther., 266, 306-313.